About 100 preliminary reports of Guillain-Barr\u00e9 have been detected after 12.8 million doses of Johnson & Johnson vaccine were administered<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
MONDAY, July 12, 2021 (HealthDay News) — The U.S. Food and Drug Administration issued a new warning for the Johnson & Johnson COVID-19 vaccine that says the shot has been tied to Guillain-Barr \u00a9 syndrome.<\/p>\n
Officials said there is a “small possible risk” for the side effect, and said it is not entirely clear that it was caused by the vaccine, the Associated Press <\/em>reported. <\/span><\/p>\n About 100 preliminary reports of Guillain-Barr \u00a9 have been detected after 12.8 million doses of Johnson & Johnson vaccine were administered, the U.S. Centers for Disease Control and Prevention said in a statement, The Washington Post<\/em> reported. These cases have largely been reported about two weeks after vaccination and occurred mostly in men, many aged 50 years and older. Most people fully recover, but a few have permanent nerve damage, according to the CDC.<\/p>\n Available data do not show a pattern suggesting a similar increased risk with the Pfizer and Moderna mRNA vaccines. The Guillain-Barr \u00a9 cases will be discussed as part of an upcoming meeting of CDC advisers, the agency said, according to T<\/em>he Post<\/em>.<\/p>\n Associated Press<\/em> Article<\/a><\/p>\n